Who cure Yellow Fever?[急！！]

Yellow fever (also called yellow jack, black vomit or vomito negro in Spanish, or sometimes American Plague) is an acute viral disease. It is an important cause of hemorrhagic illness in many African and South American countries despite existence of an effective vaccine. The yellow in the disease name refers to the jaundice that affects some patients.[1]
Yellow fever has been a source of several devastating epidemics. During the Haitian Revolution in 1802, the French soldiers were attacked by yellow fever. More than half of the army perished due to the disease. Outbreaks followed by thousands of fatalities occurred periodically in other Western Hemisphere locations until research which included human volunteers (some of whom died) led to an understanding of the method of transmission to humans (primarily by mosquitos) and development of a vaccine and other preventative efforts in the early 20th century.
Despite the costly and sacrificial breakthrough research by Cuban physician Carlos Finlay, American physician Walter Reed and many others, over 100 years later, unvaccinated populations in many developing nations in Africa and Central and South America continue to be at risk.[2] As of 2001, the World Health Organization (WHO) estimates that yellow fever causes 200,000 illnesses and 30,000 deaths every year in unvaccinated populations.


圖片參考：http://upload.wikimedia.org/wikipedia/commons/thumb/4/45/YellowFeverVirus.jpg/240px-YellowFeverVirus.jpg


Research data
In the hamster model of yellow fever, early administration of the antiviral ribavirin is an effective early treatment of many pathological features of the disease.[10] Ribavirin treatment during the first five days after virus infection improved survival, reduced tissue damage in target organs (liver and spleen), prevented hepatocellular steatosis, and normalized alanine aminotransferase (a liver damage marker) levels. The results of this study suggest that ribavirin may be effective in the early treatment of yellow fever, and that its mechanism of action in reducing liver pathology in yellow fever virus infection may be similar to that observed with ribavirin in the treatment of hepatitis C, a virus related to yellow fever.[10] Because ribavirin had failed to improve survival in a virulent primate (rhesus) model of yellow fever infection, it had been previously discounted as a possible therapy.